Hip Replacement Implants Market Size & Growth Forecast 2027–2036, By Segments (End-use, Product Type, Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Hip Replacement Implants Market size stood at USD 5.1 billion in 2026 and is predicted to grow at a 2% CAGR from 2027 to 2036, surpassing USD 6.22 billion by 2036. The industry revenue for 2027 is estimated at USD 5.19 billion.
Get more details on this report
Request Free Sample ReportHip Replacement Implants Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to strong orthopedic infrastructure, high procedure volumes, and widespread access to advanced implants across hospitals and ambulatory settings supporting steady demand.
- Asia Pacific is growing at 2.51% CAGR, driven by improving access to orthopedic surgery, expanding hospital capacity, and gradual adoption of modern implant techniques and procedures.
Segment Momentum
- Hospitals & Surgery Centers held 67.12% of the market in 2026 due to their comprehensive surgical infrastructure, perioperative care capabilities, and multidisciplinary support required throughout hip replacement procedures.
- Revision Hip is the fastest-growing product type as more patients require follow-on procedures to address implant wear, loosening, and other complications associated with previous hip replacements.
Market Expansion Drivers
- Rising osteoarthritis and obesity prevalence increasing demand for hip replacement procedures globally.
- Advancements in minimally invasive and cement-less hip replacement technologies improving surgical outcomes.
- Expanding reimbursement coverage improving patient access to orthopedic implant procedures.
Leading Market Participants
- Top players in the hip replacement implants market include Zimmer Biomet (United States), Johnson & Johnson (United States), Stryker Corporation (United States), Smith & Nephew plc (United Kingdom), MicroPort Scientific Corporation (China), Exactech, Inc. (United States), OMNIlife Science, Inc. (United States), B. Braun Melsungen AG (Germany), DJO Global, Inc. (United States), Aesculap Implant Systems, LLC (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.1 billion
- 2027 Estimated Market Size: USD 5.19 billion.
- Projected Market Size: USD 6.22 billion by 2036
- Growth Forecast: 2% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals & Surgery Centers (End-use) | Total Hip (Product Type) | Metal-on-polyethylene (Material)
- Emerging Opportunity Segment: Orthopedic Clinics (End-use) | Revision Hip (Product Type) | Ceramic-on-polyethylene (Material)
Market Growth Drivers and Industry Trends
Rising osteoarthritis and obesity prevalence increasing demand for hip replacement procedures globally
The increasing prevalence of osteoarthritis and obesity is contributing to a larger population experiencing mobility limitations, joint deterioration, and chronic hip pain. This disease burden will drive the hip replacement implants market growth as patients with advanced joint damage increasingly require surgical intervention to restore mobility and improve functional outcomes. Rising demand for orthopedic care is also encouraging healthcare providers to strengthen access to hip replacement procedures for patients whose symptoms cannot be adequately managed through conservative treatment.
Advancements in minimally invasive and cement-less hip replacement technologies improving surgical outcomes
Technological progress in hip replacement is enabling surgeons to adopt procedures designed to reduce tissue disruption and improve implant integration. The hip replacement implants market is benefiting from minimally invasive approaches and cement-less implant technologies that can support more natural fixation, reduce dependence on bone cement, and facilitate postoperative recovery. Improvements in implant design and surgical techniques are also giving orthopedic specialists greater flexibility in selecting procedures according to patient anatomy and clinical requirements.
Expanding reimbursement coverage improving patient access to orthopedic implant procedures
Broader reimbursement coverage can reduce the financial barriers associated with major orthopedic procedures, making hip replacement more accessible to eligible patients. Improved insurance and healthcare reimbursement policies will propel the hip replacement implants market by supporting greater utilization of implant-based interventions among patients requiring surgical treatment. More favorable coverage conditions can also enable healthcare providers to perform procedures that might otherwise be deferred because of treatment affordability concerns.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising osteoarthritis and obesity prevalence increasing demand for hip replacement procedures globally | 1.80% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in minimally invasive and cement-less hip replacement technologies improving surgical outcomes | 1.50% | High | North America, Europe | Medium | Mid Term |
| Expanding reimbursement coverage improving patient access to orthopedic implant procedures | 1.20% | High | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the hip replacement implants market in 2026, supported by advanced healthcare infrastructure, high availability of specialized orthopedic care, and strong demand for joint replacement procedures. The region benefits from widespread access to experienced orthopedic specialists, modern surgical facilities, and advanced implant technologies, which support the adoption of hip replacement procedures. An aging population, increasing prevalence of joint-related disorders, and greater emphasis on restoring mobility and quality of life also sustain procedure volumes. In addition, established reimbursement systems and ongoing investment in healthcare technologies strengthen patient access to elective orthopedic interventions and support the region's leading market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to be the fastest-growing regional market, driven by improving healthcare infrastructure, expanding access to orthopedic services, and rising awareness of advanced joint replacement procedures. Growing healthcare investment across emerging economies is enabling the development of modern hospitals and specialized surgical centers, while improvements in medical training are increasing the availability of skilled orthopedic professionals. Demographic aging, rising incidence of musculoskeletal conditions, and increasing demand for treatments that improve mobility are further expanding the addressable patient population. The gradual adoption of advanced implant technologies and improvements in healthcare accessibility are expected to reinforce the region's growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Manufacturing FocusGermany prioritizes high-quality implant engineering supported by strong orthopedic expertise and established medical device manufacturing. Hospitals increasingly value durable implant systems and evidence-based technologies that enhance procedural efficiency and long-term clinical performance.
France 🇫🇷
Clinical Quality IntegrationFrance supports the adoption of hip replacement implants through established orthopedic care pathways and strong emphasis on clinical effectiveness. Healthcare providers continue evaluating implant technologies that balance long-term performance with efficient surgical practices.
Italy 🇮🇹
Specialized Surgical DemandItaly maintains consistent demand for hip replacement implants through specialized orthopedic centers managing degenerative joint conditions. Clinical priorities include implant durability, surgeon familiarity with proven systems, and techniques that contribute to improved rehabilitation outcomes.
Japan 🇯🇵
Aging Care SolutionsJapan's hip replacement implants market is shaped by growing demand for solutions that address mobility challenges associated with an aging population. Clinical attention remains focused on minimally invasive procedures and implants designed to improve recovery while supporting long-term patient function.
South Korea 🇰🇷
Smart Orthopedic AdoptionSouth Korea is expanding the use of digitally enabled orthopedic procedures supported by modern hospital infrastructure. Demand for hip replacement implants increasingly favors innovative materials and navigation-assisted surgical techniques that strengthen procedural accuracy and patient care.
United States 🇺🇸
Procedure Innovation HubThe U.S. emphasizes advanced hip replacement implants that improve surgical precision, implant longevity, and patient recovery. Healthcare providers continue integrating robotic-assisted procedures and data-driven planning to optimize orthopedic treatment outcomes across diverse patient groups.
Segment Leadership and Growth Trends
Hip Replacement Implants Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals & Surgery Centers (Largest Segment) vs Orthopedic Clinics (Fastest-Growing Segment)
Hospitals & surgery centers accounted for the largest share of the hip replacement implants market at 67.12% in 2026, reflecting their central role in performing complex orthopedic procedures and providing comprehensive surgical care. These facilities offer access to specialized surgeons, advanced imaging, operating infrastructure, and postoperative rehabilitation, making them key settings for hip replacement procedures. Increasing demand for joint reconstruction and continued improvements in surgical techniques and implant technologies are supporting sustained utilization within hospital-based care.
Orthopedic clinics are experiencing faster growth as healthcare delivery increasingly emphasizes specialized, accessible, and patient-focused musculoskeletal care. Dedicated orthopedic facilities can streamline consultations, diagnostic evaluation, treatment planning, and follow-up for patients requiring joint procedures. Growing preference for specialized orthopedic services, improvements in outpatient care pathways, and increasing efforts to reduce treatment burdens are supporting the expansion of implant-related services through orthopedic clinics.
Product Type Segment Analysis: Total Hip (Largest Segment) vs Revision Hip (Fastest-Growing Segment)
The total hip segment led the hip replacement implants market with a 39.86% share in 2026, supported by its established role in treating advanced hip joint degeneration and restoring mobility among patients with significant joint damage. Total hip replacement provides comprehensive reconstruction of the damaged joint and remains a widely adopted option for patients requiring substantial functional restoration. Rising demand for effective mobility restoration, improvements in implant design, and increasing adoption of modern orthopedic surgical techniques continue to support this segment.
Revision hip implants are advancing rapidly as the need to address failed, worn, or otherwise compromised primary hip replacements increases. Revision procedures often require specialized implant designs capable of addressing bone loss, implant instability, or changes in the surrounding joint structure. Growing numbers of patients with previous hip replacements, combined with continued improvements in revision techniques and implant customization, are supporting increasing demand for revision hip solutions.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals & Surgery Centers, Orthopedic Clinics, Others | Hospitals & Surgery Centers | Orthopedic Clinics |
| Product Type | Total Hip, Partial Femoral Head, Hip Resurfacing, Revision Hip | Total Hip | Revision Hip |
| Material | Metal-on-metal, Metal-on-polyethylene, Ceramic-on-polyethylene, Ceramic-on-metal, Ceramic-on-ceramic | Metal-on-polyethylene | Ceramic-on-polyethylene |
Competitive Landscape and Market Positioning
Major players in the hip replacement implants market:
1. Zimmer Biomet (United States)
2. Johnson & Johnson (United States)
3. Stryker Corporation (United States)
4. Smith & Nephew plc (United Kingdom)
5. MicroPort Scientific Corporation (China)
6. Exactech Inc. (United States)
7. OMNIlife Science Inc. (United States)
8. B. Braun Melsungen AG (Germany)
9. DJO Global Inc. (United States)
10. Aesculap Implant Systems LLC (Germany)
The push for higher durability in orthopedics has triggered the introduction of next-generation biocompatible structures designed for younger, more active demographics. This wave of specialized hardware introductions ensures the hip replacement implants market directly addresses long-term wear issues and reduces the likelihood of secondary revision surgeries.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zimmer Biomet (United States) | |||||||
| Johnson & Johnson (United States) | |||||||
| Stryker Corporation (United States) | |||||||
| Smith & Nephew plc (United Kingdom) | |||||||
| MicroPort Scientific Corporation (China) | |||||||
| Exactech Inc. (United States) | |||||||
| OMNIlife Science Inc. (United States) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| DJO Global Inc. (United States) | |||||||
| Aesculap Implant Systems LLC (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| JointMedica | Apr-26 | JointMedica reached full enrollment for its U.S. Investigational Device Exemption (IDE) study of the Polymotion Hip Resurfacing System. This bone-conserving technology utilizes a proprietary metal-on-polyethylene articulation to provide a viable alternative to traditional total hip replacement, marking a critical step toward potential commercialization and competitive entry into the hip preservation market. |
| Hip Innovation Technology, LLC | Feb-24 | Hip Innovation Technology unveiled its flagship Reverse Hip Replacement System (Reverse HRS) at the 2024 AAOS annual meeting. Designed to address instability and dislocation risks, the metal-on-polyethylene system features a unique "reverse" geometry that optimizes stability and range of motion, representing a strategic technological advancement in orthopedic joint reconstruction for complex patient cases. |
| Smith+Nephew | Aug-23 | Smith+Nephew launched the OR3O Dual Mobility System in India, introducing a specialized implant design that utilizes a small-diameter femoral head with a large polyethylene insert. This configuration enhances joint stability and range of motion while reducing dislocation risks, strategically strengthening the company’s portfolio for primary and revision hip arthroplasty in the high-growth Asia-Pacific market. |
| Stryker | Aug-23 | Stryker initiated a nationwide marketing campaign, “Scan. Plan. Mako Can.,” to drive patient awareness of its Mako SmartRobotics system. By aligning clinical technology with direct-to-patient communication, the initiative aims to increase adoption rates for robotic-assisted hip joint replacement, strengthening the company’s competitive positioning and market share in the digital and robotic-assisted orthopedic surgery segment. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Hip Replacement Implants Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Fixation Method | Cemented, Cementless, Hybrid |
| Surgical Approach | Posterior Approach, Anterior Approach, Lateral Approach, Anterolateral Approach |
| Indication | Osteoarthritis, Rheumatoid Arthritis, Femoral Neck Fracture, Avascular Necrosis, Other Indications |
Hip Replacement Implants Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Hospital Procurement and Purchasing Strategy |
|
| Reimbursement and Patient Access Landscape |
|
| Revision Surgery Demand and Opportunity Outlook |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the hip replacement implants market?
What is the forecasted size of the hip replacement implants industry?
How are advancements in minimally invasive and cement-less technologies influencing hospital purchasing decisions?
Why is expanding reimbursement coverage important for growth in the hip replacement implants market?
Why do Hospitals & Surgery Centers account for the largest share of the hip replacement implants market?
What is driving growth in the Revision Hip segment?
Why is North America the largest market for hip replacement implants?
What factors are supporting Asia Pacific growth in hip replacement implants?
Which companies are driving growth in the hip replacement implants landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization